Remel Xpect C. difficile Toxin A/B Test

Tuesday, 06 April, 2010 | Supplied by: Oxoid Australia Pty Ltd


The Remel Xpect C. difficile Toxin A/B Test is a diagnostic tool for use in the rapid detection of Clostridium difficile infection (CDI). It is easy to use and provides accurate and reliable results in just 20 minutes. This speed and convenience enables healthcare professionals to quickly and decisively initiate appropriate patient care and infection control procedures.

The test allows the direct detection of both C. difficile toxins A and B in faecal samples. Diluted sample is simply mixed with a conjugate buffer and added to the test cassette. Within 20 minutes, the result is clearly visible and easily interpreted. No specialised equipment or expertise is required.

Xpect Clostridium difficile Toxin A/B test is suitable for use in laboratories of any size.

The speed and convenience of Xpect Clostridium difficile Toxin A/B test allows more laboratories and healthcare facilities to test for this rapidly spreading pathogen immediately, giving them faster results and the opportunity to respond quickly and efficiently to a positive result.

Online: www.oxoid.com.au
Phone: 08 8238 9052
Related Products

Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research

Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...

TopoGEN Topoisomerase Assay Kits

TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...

Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis

The multiplex panel encompasses a wide selection of proteins essential for studying key...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd